drugset / Trial / NCT04532801

Evaluation of Kisspeptin Glucose-Stimulated Insulin Secretion With Physiologic Mixed Meal Tolerance

NCT04532801 ↗

Phase 1 Withdrawn Massachusetts General Hospital
RandomizedCrossoverQuadruple-blindOther

Summary

This study utilizes infusions of kisspeptin in healthy women to isolate the impact of kisspeptin on beta-cell responsivity assessed by the mixed meal tolerance test.

Timeline

Start
2019-09-01
Primary completion
2024-08-31
Completion
2024-12-21

Outcome

Outcome not reported

Stopped (Enrollment): “Interim analysis of data collected under other clinical trials demonstrated planned enrollment was insufficiently powered.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Kisspeptin-10 Peptide — Intravenous